长期药物治疗中的戒烟治疗的代谢组和肠道微生物生物标志物:一项随机对照试验
Theoretical Framework: Cigarette smoking is the leading preventable cause of death worldwide, with nicotine dependence notably common among individuals with Substance Use Disorders (SUD). Smoking exacerbates both physical and mental health issues, further complicating the treatment of SUD. Current therapeutic approaches for SUD often prove inadequate, indicating a need for new strategies. Recent advancements in metabolomics and gut microbiome research have provided valuable insights into the biological mechanisms underlying addiction.
Objectives: This study aims to investigate the therapeutic potential of smoking cessation for individuals with SUD, using a six-week intervention within a therapeutic community. The research specifically explores the psychobehavioral, metabolic, and gut microbiome domains. It is hypothesized that smoking cessation will improve emotional regulation, self-efficacy, and reduce substance craving, mediated by changes in metabolic and microbiome profiles linked to brain reward systems.
Methods: A randomized controlled trial (N=150) will be conducted, examining outcomes such as clinical relapse rates, microbial and metabolic markers, particularly in choline and folate metabolism. Participants with SUD (n=100) will undergo a six-week smoking cessation intervention, with pre- and post-assessments, compared to a control group receiving treatment as usual. Metabolomic and microbiome analyses will be conducted using blood and stool samples, alongside psychological assessments via questionnaires. Assessments on a behavioural level will take place at a 3-months follow-up.
A cross-sectional, non-interventional healthy control group (n=50) will be examined at a single timepoint with an anologous panel of psychological variables, blood and stool to ascertain differences between smokers with SUD and healthy controls.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Fehring、奥地利、8350
- Grüner Kreis Organization Johnsdorf Facility
-
Graz、奥地利、8036
- Medical University Graz
-
Vienna、奥地利、1020
- Sigmund Freud Private University Vienna
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- diagnosis of a form of substance use disorder (F1x.x) by a licensed psychiatrist according to ICD-10
- minimum age of 18 years
- sufficient knowledge of the German language
- willingness to quit smoking
- willingness and ability to consent
Inclusion criteria for healthy controls :
- minimum age of 18 years
- sufficient knowledge of the German language
- willingness and ability to consent
Exclusion Criteria:
- lack of consent, inability to provide informed consent
- age below 18,
- acute psychotic symptoms or acute suicidal tendencies
- cardiovascular disease
- pregnancy or breastfeeding
- severe mental or organic illnesses (such as epilepsy, brain tumors, recent major surgery), tumor diseases, dementia (Mini Mental Score <20), severe autoimmune diseases or immunosuppression, acute infections, or acute diarrhea, prior gastrointestinal surgery (except appendectomy)
- probiotic intake within the last 6 months,
- ongoing consumtion of dietary supplements, probiotics, antibiotics, or prebiotic supplements during the study
- prior participation in a smoking cessation programme
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Treatment As Usual
Patients in the TAU group receive long-term rehabilitation drug treatment according to the 'community as a treatment'-model |
The standard treatment within the 'Grüner Kreis' therapeutic community - which all participants will receive - consists of group therapy (once a week), individual psychotherapy (once a week), counselling by social workers, psychiatric consultations, as well as sport-, art- and work-therapy. Daily life is organized according to principles of therapeutic community-based addiction treatment. |
|
实验性的:6-weeks smoking cessation cognitive-behavioral therapy intervention
The "smoke free in 6 weeks" program is a standardized behavioural therapy intervention that takes place once a week for 1.5 hours over 6 weeks and is provided by the Austrian health insurance provider Österreichische Gesundheitskasse (ÖGK). |
The standard treatment within the 'Grüner Kreis' therapeutic community - which all participants will receive - consists of group therapy (once a week), individual psychotherapy (once a week), counselling by social workers, psychiatric consultations, as well as sport-, art- and work-therapy. Daily life is organized according to principles of therapeutic community-based addiction treatment. Held in the therapeutic community, the intervention will employ principles of cognitive-behavioural therapy (CBT) coupled with personalized recommendations for nicotine replacement. The Austrian Health Insurance standard for therapy will be guiding the program's content, which is tailored for inpatient clients. Specifically, the following interventions based on CBT techniques will be applied in the weekly group sessions consisting of 10 to 15 participants: Psychoeducation including information on tobacco addiction, health risks, advice on relapse prevention and the handling of craving, motivation building, behavioural observation. |
|
无干预:Healthy controls
Control group with n=50 healthy adult subjects, examined at a single timepoint. No interventions will be administered in this arm. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Self-efficacy
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period
|
Self-efficacy as a psychological variable and will be assessed by the Self-Efficacy Scale (SWE), a self-report instrument for measuring general optimistic self-confidence. It consists of 10 items and measures optimistic competence expectancy, i.e., confidence in solving difficult situations with one's own abilities. |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period
|
|
General substance-related craving
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
Substance related craving will be assessed by the MaCS (Mannheim Craving Scale). consists of 12 items and four additional items and is rated on a 5- point Likert scale. |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
|
Tobacco dependence
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
Tobacco dependence will be assessed by The Fagerström Test for Cigarette Dependence (formerly Fagerström Test for Nicotine Dependence; FTND). It consists of 6 categorically scaled items that assess the number of smoked cigarettes per day (CPD), compulsive use, and dependence intensity. |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
|
Primary Affects
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
Primary Affects, as proposed by Jaak Panksepp will be assessed by the German Version of the Brief Affective Neuroscience Personality Scales including a LUST Scale (BANPS-GL), a self-report questionnaire. |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
|
Metabolome
大体时间:From enrollment to the end of the 6-weeks treatment period.
|
Metabolome will be ascertained from blood via state-of-the-art NMR (nuclear magnetic resonance). |
From enrollment to the end of the 6-weeks treatment period.
|
|
Gut microbiome
大体时间:From enrollment to the end of the 6-weeks treatment period.
|
Gut microbiome will be ascertained via 16s-rRNA sequencing from stool. |
From enrollment to the end of the 6-weeks treatment period.
|
|
Smoking behaviour
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
Participants will be asked regarding their daily smoked cigarettes in the last two weeks (interval scaled). A second single item question will be, if participants have been completely abstinent from tobacco smoking in the last two weeks (dichotome). |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Psychiatric Symptoms
大体时间:From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
For the evaluation of psychopathology, the ICD-10 Symptom Rating (ISR) questionnaire will be utilized. In accordance with the ICD-10, this self-assessment questionnaire, comprising 30 items, is designed to comprehensively assess the status and severity of mental disturbances. Symptoms of the six symptomatic patterns - depressive, anxiety, obsessive-compulsive, eating disorders, somatoform syndrome, and post-traumatic stress disorder - are assessed. |
From enrollment to follow-up 3 months after the end of the 6-weeks treatment period.
|
合作者和调查者
出版物和有用的链接
一般刊物
- Fuchshuber J, Schober H, Wohlmuth M, Senra H, Rominger C, Schwerdtfeger A, Unterrainer HF. The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in patients with addiction undergoing long-term rehabilitation: a quasi-experimental pilot study. BMC Med. 2024 May 1;22(1):184. doi: 10.1186/s12916-024-03405-z.
- Peter J, Pritz A, Hiebler M, Mahmoudi M, Fuchshuber J, Morkl S, Holasek S, Humer E, Unterrainer HF. Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial. Front Psychiatry. 2026 Mar 3;17:1677235. doi: 10.3389/fpsyt.2026.1677235. eCollection 2026.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.